← Eichor
Study identifier: NCT06712758 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Low Intraocular Pressure Cataract Surgery With Zeiss Quatera in Glaucoma Patients

Condition: Cataract · Glaucoma  ·  Sponsor: Visionair Oogzorg

PhaseN/A
Planned participants10
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

You were selected to participate in this observational study because you suffer from glaucoma and cataracts. For the cataract you will have cataract surgery. This study will not affect your treatment, it will only collect data on what is performed before, during and after the procedure. The aim of this data collection is to demonstrate the safety of a new generation of cataract surgical devices in patients who also suffer from glaucoma. They are glaucoma patients who have an increased sensitivity to eye pressure increases both during and after surgery. The new surgical device makes it possible to safely perform cataract surgery under low pressures. This could, at least theoretically, provide an advantage for patients who also suffer from glaucoma.

This description comes directly from the study's public registry record.

Talk to the study team

Koen Willekens, Prof  ·  003214808311  ·  kw@visionairoogzorg.be

Sien Boons  ·  003216715634  ·  sb@visionairoogzorg.be

Always discuss trial participation with your own doctor first.

Locations (1)

Visionair OogzorgGeel, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06712758